DiaMedica Therapeutics Inc. financial data

Symbol
DMAC on Nasdaq
Location
301 Carlson Parkway, Suite 210, Minneapolis, MN
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 12, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 887 % -53.6%
Return On Equity -79 % -105%
Return On Assets -69.9 % -91.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 51.7M shares +20.9%
Common Stock, Shares, Outstanding 43.1M shares +0.89%
Entity Public Float 71M USD
Common Stock, Value, Issued 0 USD
Weighted Average Number of Shares Outstanding, Basic 43M shares +12.8%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 22.9M USD +57.6%
General and Administrative Expense 8.52M USD +8.82%
Operating Income (Loss) -31.5M USD -40.5%
Nonoperating Income (Expense) 314K USD -40.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -29.6M USD -48.8%
Income Tax Expense (Benefit) 28K USD -34.9%
Net Income (Loss) Attributable to Parent -29.6M USD -48.6%
Earnings Per Share, Basic 0 USD/shares -35.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 4.11M USD -70.8%
Marketable Securities, Current 25.9M USD -35.2%
Cash, Cash Equivalents, and Short-term Investments 30M USD -44.5%
Accounts Receivable, after Allowance for Credit Loss, Current 161K USD -58.8%
Assets, Current 31.1M USD -43.5%
Property, Plant and Equipment, Net 152K USD 0%
Operating Lease, Right-of-Use Asset 239K USD -24.6%
Assets 31.5M USD -44.6%
Accounts Payable, Current 1.26M USD +66.1%
Employee-related Liabilities, Current 590K USD +24.7%
Accrued Liabilities, Current 2.75M USD +23.2%
Liabilities, Current 4.12M USD +33.3%
Operating Lease, Liability, Noncurrent 176K USD -35.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax -14K USD +72.5%
Retained Earnings (Accumulated Deficit) -155M USD -23.5%
Stockholders' Equity Attributable to Parent 27.2M USD -49.1%
Liabilities and Equity 31.5M USD -44.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -7.15M USD -7.46%
Net Cash Provided by (Used in) Financing Activities 91K USD
Net Cash Provided by (Used in) Investing Activities 6.62M USD +57.4%
Common Stock, Shares, Issued 43.1M shares +0.89%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -436K USD +82.2%
Deferred Tax Assets, Valuation Allowance 34.2M USD +21.9%
Operating Lease, Liability 272K USD -23.8%
Depreciation 11K USD +37.5%
Payments to Acquire Property, Plant, and Equipment 12K USD +33.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -29.5M USD -48.5%
Lessee, Operating Lease, Liability, to be Paid 302K USD -26.9%
Property, Plant and Equipment, Gross 280K USD +12%
Operating Lease, Liability, Current 96K USD +12.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 119K USD +2.59%
Lessee, Operating Lease, Liability, to be Paid, Year One 116K USD +2.66%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 30K USD -46.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 10K USD -91.6%
Deferred Tax Assets, Operating Loss Carryforwards 32.2M USD +23.8%
Lessee, Operating Lease, Liability, to be Paid, Year Four 10K USD -91.6%
Additional Paid in Capital 183M USD +1.84%
Deferred Tax Assets, Net of Valuation Allowance 34.2M USD +21.9%
Share-based Payment Arrangement, Expense 2.79M USD +54.1%